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ABSTRACT
The considerable gap between what we know from
research and what is done in clinical practice is well
known. Proposed responses include the
Evidence-Based Medicine (EBM) and Clinical Quality
Improvement. EBM has focused more on ‘doing the
right things’dbased on external research
evidencedwhereas Quality Improvement (QI) has
focused more on ‘doing things right’dbased on local
processes. However, these are complementary and in
combination direct us how to ‘do the right things right’.
This article examines the differences and similarities in
the two approaches and proposes that by integrating
the bedside application, the methodological
development and the training of these complementary
disciplines both would gain.
INTRODUCTION
Those working in healthcare are aware of the
considerable gap between what we know from
researchandwhatisdoneinclinicalpractice.
1
For example, enforced bed rest is ineffective
in several conditions where it is still used;
exercise reduces mortality in heart failure but
is rarely used; and brief counselling after
trauma is fashionable but ineffective. The
response to this well-documented problem
includes both Evidence-Based Medicine
(EBM)
23andClinicalQualityImprovement.
45
The term EBM was coined by Gordon
Guyatt in 1992 for the JAMA ‘User Guide’
series to describe the bedside use of research
to improve patient care. At the time it was
common at McMaster teaching hospitals for
patients’ notes to include a key research
paper relevant to their care, and for this to be
discussed at ward rounds (personal observa-
tiondPG). Improved information tech-
nology allowed Dave Sackett’s team to use an
‘evidence cart’ on ward rounds at the John
Radcliffe in Oxford; the team asked and
answered two questions for every three
patients, with the searches changing 1/3 of
clinical decisions.
6 Different specialties and
different individuals have adopted the prin-
ciples of EBM to different degrees and in
vastly different ways (Interviews on www.
cebm.net/index.aspx?o¼4648 illustrate this
diversity).
In parallel, the Quality Improvement (QI)
movement emerged to address similar prob-
lems, but with a focus on recurrent problems
within systems of care. The ﬁrst methods
used in the National Demonstration Projects
in the 1980s were adopted from those
introduced by Deming into industry.
4 But the
methods soon evolved to the different envi-
ronment of healthcare, with the founding of
the Institute for Healthcare Improvement,
and the development of the breakthrough
series collaborative, the model for improve-
ment, and other modiﬁcations and exten-
sions of QI methods.
EBM and QI have had overall similar goals
but focus on different parts of the problem.
EBM has focused more on ‘doing the right
things’: actions informed by the best available
evidence from our clinical knowledge base
(ﬁgure 1) ,w h e r e a sQ Ih a sf o c u s e dm o r eo n
‘doing things right’: making sure that intended
actions are done thoroughly, efﬁciently and
reliably; however, these are complementary
(ﬁgure 1) and in combination direct us how to
‘do the right things right’.
7
Before ‘ﬁxing’ an evidenceepractice gap,
we would be wise to ask ‘is this the right thing
to do?’ Is there really a problem? Is there
something effective we can do about it? For
example, many QI initiatives in diabetes had
aimed to achieve low HbA1c levels
8 for which
the evidence was weak, and subsequent large
scale randomised trials (ACCORD and
ADVANCE) have suggested may be unhelpful
or even harmful.
9
1Centre for Research into
Evidence-Based Practice,
Faculty of Health Sciences
and Medicine, Bond
University, Queensland,
Australia
2Community and Family
Medicine and Medicine,
White River Junction VA
Medical Center, Dartmouth
Medical School, Hanover,
New Hampshire, USA
3Oncology, Pediatrics,
Epidemiology and
Biostatistics, Johns Hopkins
Schools of Medicine and
Public Health, Baltimore,
Maryland, USA
Correspondence to
Paul Glasziou, Centre for
Research into
Evidence-Based Practice,
Faculty of Health Sciences
and Medicine, Bond
University, Gold Coast,
Queensland 4229, Australia;
pglaszio@bond.edu.au
Accepted 17 October 2010
This paper is freely available
online under the BMJ
Journals unlocked scheme,
see http://qualitysafety.bmj.
com/site/about/unlocked.
xhtml
BMJ Qual Saf 2011;20(Suppl 1):i13ei17. doi:10.1136/bmjqs.2010.046524 i13
The structure of improvement knowledgeThe ‘right things right’ process might be illustrated by
a familiar clinical example. In the clinic of one of the
authors, the primary care team was considering whether
to try to wean elderly patients from long-term benzodi-
azepines being given for insomnia. We and the patients
seemed reluctant. However, the team reviewed the
evidence
10 and found the risk of falls on benzodiaze-
pines was higher than we’d expected and other adverse
effects, such as cognitive loss, added to the problems. So
cessation was the ‘right thing’, but how best to achieve
this? A review of the controlled trials showed weaning
was possible, but that simple (but very slow) tapering was
as effective as more intensive methods such as cognitive
therapy counselling. Finally, sending a structured letter
to the patient (on why and how to withdraw) had also
been shown to be effective.
11 Without this evidence
review by the clinical team, we might have wasted a lot of
effort on ineffective means to achieve our goal. But
without a clinical improvement process to change our
practice, this knowledge might not have provoked
action. Of course, QI would also suggest additional
questions such as how many patients are on which
benzodiazepines and for how long? How many falls or
other adverse events have occurred on the benzodiaze-
pines? What will occur with our patient’s anxiety once we
remove the medication?
This article aims to look at what each of these disci-
plinary areas might learn from the other. The difference
in approach of the two disciplines may be better
understood by looking at the problem each perceives it
is addressing.
The EBM perspective
One cause of the evidenceepractice gap is information
overload, for example, approximately 8000 refer-
encesdincluding around 350 randomised trialsdare
added to MEDLINE each week. But only a small fraction
of this is research that is sufﬁciently valid and relevant to
change practice. So keeping up to date with new devel-
opments and information is problematic. One arm of
EBM has been to synthesise and summarise this ﬂood of
research, and be able to access evidence wherever and
whenever it is needed. To achieve this requires both
ready access (to resources such as MEDLINE and the
Cochrane Library) and skills (in ﬁnding, appraising and
applying evidence) that few healthcare workers currently
have. The EBM movement has focused on developing
both the skills and tools to better connect research and
clinical practice, with some
12 but not universal successes.
A particular focus of EBM has been to take a more
sceptical approach to innovation, asking for clear
evidence before changing practice. Given that few
innovations represent a real advance, this cautious
approach means less disruption arising from unneces-
sary changes in practice.
13
The QI perspective
The problem addressed by the QI approach might be
characterised as the ‘knowingedoing’ gap: we know
(individually and collectively) what to do, but fail to do it
or fail to do it correctly. The gap has many causes, from
simple lack of (some individuals) knowledge about what
should be done, to uncertainties about the ‘how to’. For
example, we may know that certain groups of patients
should receive inﬂuenza vaccine but fail to do this
because the system does not encourage reliable admin-
istration of the vaccine.
For example, at one institution, the electronic medical
record (EMR) was fully implemented for many years, so
the physicians-in-training, the staff physicians and nurses
trusted the EMR. On discharge from the hospital
a prompt in the EMR enquired whether a patient
needed to receive the inﬂuenza vaccine. No one realised
that this prompt led to a blind alleydno vaccine was
ordered and no vaccine was given. The individuals (and
the EMR) knew that inﬂuenza vaccine was the ‘right
thing to do’, but the EMR and the culture of trusting the
EMR inhibited ‘doing the right thing’. Fixing this
problem proved to be a challengedrequiring several
PlaneDoeStudyeAct iterations. The simple change in
the EMR system and the inﬂuenza vaccine ordering were
low on the priority list for the IT support group. This
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Figure 1 Relationships between Quality Improvement (QI)
and Evidence-Based Medicine (EBM). (a) sequence of EBM
followed by QI; (b) EBM uses clinical knowledge to inform
individual clinical decisions about patient care; (c) QI focuses
on improving recurrent problems in the processes of care
(Acronyms: GINdGuidelines International Network;
EPOCdEffective Practice and Organisation of Care Group;
IHIdInstitute for Healthcare Improvement; BEMEdBest
Evidence Medical Education).
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The structure of improvement knowledgenecessitated that the care team create a work-around and
learn how to reliably ‘do the right thing’ in the context
and setting of care.
14 Even an intervention as simple as
administering inﬂuenza vaccine in a fully integrated
EMR environment required a thorough knowledge of
the system and then creativity in dealing with its limi-
tationsdmuch more than just the knowledge of the
‘right thing’.
The techniques of QI have focused on integrating
what we know and moving it to how we should be doing
it. Common techniques to achieve this are reminder
systems (paper or computer), simpliﬁcation of processes
(reducing unnecessary steps), structuring the system to
do the right thing at the right time and place (putting
hand-washing equipment and/or instructions in the
right place) and testing new interventions to determine
what works in this particular setting. This task is often
a creative and iterative process of identifying barriers,
and working out solutions to overcome these.
MARRYING EBM AND QI
As illustrated by the above examples, EBM is involved in
the early stages of checking the validity and applicability
of the available evidence to the clinical problem. This
involves the traditional ‘four steps’ of EBM illustrated in
ﬁgure 2. QI processes
15 may be triggered at the fourth
step if it seems likely that the clinical problem is
a common one for which the current system of practice
is not optimal.
16 Similarly, in the planning stage of a QI
project there may be several questions that trigger an
EBM cycle to check for evidence.
In addition to this merging of EBM and QI processes,
there are deeper organisational and epistemological
issues in common which we brieﬂy discuss in the next
section.
THE EVIDENCE FOR EBM AND QI
A common criticism levelled at both EBM and QI is that
there is only weak evidence that either process makes
a difference to patient outcomes. However, neither EBM
nor QI are a single ‘thing’ and cannot be evaluated in
the same way as a ﬁxed dose of a single chemical entity.
Rather they are disciplines with multiple techniques that
may be used to address the researchepractice gap. For
example, we know from large randomised trials that
aspirin lowers mortality after myocardial infarction, but
is underused; we would therefore want to improve
appropriate usage. EBMers might focus on the ‘appro-
priate’ part (subgroups, balance of beneﬁts and harms,
etc); QIers might focus on the usage part (barriers,
prescribing systems, etc). But success here could be
largely judged by process measuresdan increased use in
aspirindrather than in-hospital mortality. The link to
mortality has already been proven in the trials. Hence,
rather than enquire, ‘what is the evidence that EBM (or
QI) are beneﬁcial’, we should instead ask what are the
best techniques within each discipline for achieving
better practice? In order to improve, we need to know in
what circumstances do those techniques work and how
we can we disseminate those techniques?
The problems with assessing interventions by process
or outcome measurements is illustrated by a recent
systematic review
17 of QI ‘collaboratives’ that focused on
increasing the use of surfactant in premature infants. A
collaborative (sometime called ‘breakthrough collabo-
rative’) is a consortium of 20e40 healthcare organisa-
tions using QI methods on a speciﬁc healthcare quality
problem. The review found nine eligible studies,
including only two randomised trials. The reviewers
concluded that the evidence for collaboratives was
‘limited’ because the ﬁrst trial showed no effect, and the
second trial showed ‘signiﬁcant improvement in two
speciﬁc processes of care but no signiﬁcant improve-
ment in patient outcomes (mortality and pneumo-
thorax)’. However, their conclusions may ask too much
of a trial’s ability to detect real changes in outcomes. The
improvement in processes of care included a substantial
increase in surfactant use from 18% to 54% (a 36%
increase). However, given the pooled trials of surfactant,
which included 1500 randomised infants,
18 was barely
enough to demonstrate the mortality reduction,
expecting to detect a mortality reduction by the collab-
orative is unrealistic. With the 36% improvement in
surfactant use seen, to reliably detect the predicted
mortality reduction, we would require a trial of collabo-
ratives about nine times larger (931500), that is at least
13500 infants individually randomised. This may be
infeasible and unnecessary. If both steps (surfactant
effectiveness and the QI process improvement: see
Figure 2 Proposed linkage between EBM and one model for
QI.
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The structure of improvement knowledgeﬁgure 1) separately have strong evidence, then this
represents a ‘complete causal chain’ whose evidence is
equal to the evidence of the weakest link.
19 The more
important question here then is ‘What elements of the
neonatal collaboration were important?’ and ‘How well
will that transfer to other settings?’
By shifting the focus to speciﬁc methods we may ask
more focused and answerable questions. For example,
how effective are reminder systems to reduce ‘slips’? A
systematic review of trials of reminders is a valuable
resource for QI practitioners wanting to know when and
how they do or don’t work?
20 Similarly, having to support
a team’s evidence-based practice, a ‘clinical informati-
cist’ is intuitively appealing and ‘do-able’,
21 but evalua-
tive trials, which show a positive impact of clinical
informaticists on clinical decision making, are relatively
recent.
22 Some techniques, such as a QI collaborative,
may be a complex mix of techniques and therefore
intrinsically more difﬁcult to evaluate. Evaluation is still
worthwhile, but may shift focus to understanding what
methods a particular collaborative used, and what
seemed to work or not and in what circumstances.
Finally, the epistemology of both disciplines is
evolving. A better understanding of the science and
scientiﬁc rules of both areas will be important for their
continued growth and impact. For example, an early but
simplistic interpretation of EBM was that all interven-
tions required randomised trial evidence. While impor-
tant, we now recognise that different types of questions
need different types of evidence,
23 and that even for
treatment questions occasional evidence from non-
randomised studies, including some case series, can be
sufﬁciently compelling.
24
A WAY FORWARD
Early QI methods in healthcare incorporated a link to
evidence, but this connection seems to have faded over
the years. In the early 1990s, The Hospital Corporation
of America (HCA) developed and used FOCUS-PDCA
that explicitly included a detailed analysis of the
evidence for proposed changes, the processes and the
data about local performance.
25 This methodology
developed into the PDSA cycle,
15 a common, simple and
effective technique, but one where the connection to
evidence is less clear. We propose that re-establishing
a clear connection between EBM and QI will beneﬁt
both disciplines and, ultimately, beneﬁt patients and
families. For those engaged in either QI or EBM (or
hopefully both!) there are several implications, both
epistemological and practical, of the complementary
focus and methods of the two disciplines.
Those working in QI teams, before taking on a change
should routinely check the validity, applicability and
value of the proposed change and should not simply
accept external recommendations. (Corollary: At least
some members of a QI team must have high level skills
in EBM.)
Those working in EBM should recognise that it is
not sufﬁcient to simply appraise the evidence, but at
the end we should ask ‘what is the next action’
16 (and
sometimes enter a PDSA cycle) (Corollary: At least some
members of an EBM team will need high level skills
in QI.)
Those working on the methods of QI and EBM should
stop being so concerned about whether the abstract
concepts of EBM or QI ‘work’, and instead focus on
development and evaluation of speciﬁc methods of each
that sheds light on what elements are most effective in
what circumstances. This evaluation should involve two
related processes. First, recognise that ‘experiential
learning’ is a cyclic process of doing, noticing, ques-
tioning, reﬂecting, exploring concepts and models
(evidence), then doing againdonly doing it better the
next time (PDSA cycles).
26 Second, when new potential
generalisable techniques are developed, then these
should be subjected to a more formal evaluation.
Recently, several stages of evaluation speciﬁc to surgery
have been proposed,
27 which recognise the develop-
ment and learning needed before a full evaluation.
Related problems have been recognised in applying the
Medical Research Council (MRC) complex interventions
framework for health improvement.
28 However, some
creative tension between doing, developing and evalu-
ating will always exist.
Finally, those teaching the next generation of clini-
cians should value both disciplines, which should be
taught, integrated and modelled in clinical training.
29
Medical curricula, undergraduate and postgraduate, and
healthcare organisations should incorporate both EBM
and QI training and these should be taught as an inte-
gral whole. Such training requires learning background
skills and theory, but also ‘bedside’ teaching and
modelling of how EBM and QI are applied in real clin-
ical settings. By integrating the bedside application, the
methodological development, the training and the
organisation support of these complementary disci-
plines, hopefully, we can ever more frequently do the
‘right things right’.
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